| |
CINP is pleased that its relationship with Oxford University Press (OUP), as the publisher of our official Journal, the International Journal of Neuropsychopharmacology (IJNP), has progressed very nicely since its inception in 2015. The move to OUP was associated with the IJNP becoming a fully open-access journal. This has expedited articles being published more rapidly but has also broadened its availability to investigators world-wide and increased those with access to it. Evidence for this is that the total number of downloads of our articles has increased almost fourfold and now averages about 52,000/month, according to Editor-in-Chief Anthony Grace (photo).
If you would like to submit an article, please read the author guidelines before uploading. A benefit to being a CINP member with respect to the open access fee is provided, being $1500 per article for members but $2200/article for non-members.
|
The central focus of the International Journal of Neuropsychopharmacology (IJNP)
is on research that advances understanding of existing and new
neuropsychopharmacological agents including their mode of action and
clinical application or provides insights into the biological basis of
psychiatric disorders and thereby advances their pharmacological
treatment.
IJNP has an Impact Factor of 5.176 and a 5-year Impact
Factor of 5.168 according to the most recent Journal Citation Reports®
(Thomson Reuters). This places the journal 42 out of 261 in the category
of Pharmacology & Pharmacy. The Impact Factor is the average number
of times articles from the journal published in the past two years have
been cited in the JCR year. The Impact Factor is calculated by dividing
the number of citations in the JCR year by the total number of articles
published in the two previous years. The five-year Impact Factor is
calculated in the same way as the standard Impact Factor, except the
standard two-year window for inclusion of articles is extended to five
years. Dr. Pierre Blier, current CINP
president, stated, “IJNP has been an important part of the life of the
CINP and a venue for the publication of outstanding and impactful
science. Under the leadership of our editor-in-chief, Anthony Grace, our
outstanding collaboration with Oxford University Press is helping us to
increase the visibility of papers appearing in IJNP. It is also making
IJNP more user-friendly for both contributing authors and readers.” IJNP’s focus is on research which advances the understanding of
neuropsychopharmacological agents and more novel treatment modalities
such as stimulation approaches, including their clinical applications,
or which provides insights into the biological basis of neuropsychiatric
disorders and thereby advances their treatment.
Past Issues
You can find all IJNP issues from the past four years below. Click here to view all.
IJNP Team
To ensure high quality standards of the published articles, the IJNP Team consists of worldwide known experts in the field of neuropsychopharmachology who support the journal with their expertise in certain fields. The Editorial Board gives support in these activities and constantly reviews the submitted articles. Contact us
Edtior-in-Chief & Field Editors
Editor-in-ChiefDr. Anthony Grace (USA) Field Editor: Pre-Clinical Neuropsychopharmacology
Dr. David Morilak (USA)
Dr. Carla Gambarana (Italy)
Field Editor: Clinical Neuropsychopharmacology
Dr. Michael Thase (USA)
Field Editor: Neuroimaging
Dr. Gitte Moos Knudsen (Denmark)
Field Editor: Molecular Genetics & TherapeuticsDr. David Goldman (USA)
| |
IJNP Editorial Board
- Carlo Altamura (Milan, Italy)
- María Andres (Santiago, Chile)
- Celso Arango (Madrid, Spain)
- Francesc Artigas (Barcelona, Spain)
- Gabrielle Britton (Panamá, Panama)
- Jean Lud Cadet (Baltimore, USA)
- Elena Chartoff (Boston, USA)
- Sandra Comer (New York, USA)
- John Cryan (Cork, Ireland)
- Kim Do (Prilly-Lausanne, Switzerland)
- Katharina Domschke (Wuerzburg, Germany)
- Yan Dong (Pittsburgh, USA)
- Klaus Peter Ebmeier (Oxford, UK)
- Anne Eckert (Basel, Switzerland)
- Rebecca Elliott (Manchester, UK)
- Silvana Galderisi (Naples, Italy)
- Clarissa Gama (Porto Alegre, Brazil)
- Andrea Giuffrida (San Antonio, USA)
- Francisco Guimaraes (Sao Paulo, Brazil)
- Catherine Harmer (Oxford, UK)
- Wouter Koek (San Antonio, USA)
- Henry Kranzler (Philadelphia, USA)
- Rupert Lanzenberger (Vienna, Austria)
- Maria Lindskog (Stockholm, Sweden)
- Edythe London (Los Angeles, USA)
- Lin Lu (Beijing, China)
- Anil Malhotra (Glen Oaks, USA)
- Aleksander A. Mathé (Stockholm, Sweden)
- Susannah Murphy (Oxford, UK)
- Pradeep Nathan (Cambridge, UK)
- Janet Neisewander (Tempe, USA)
- Patricio O’Donnell (Cambridge, USA)
- Ghanshyam Pandey (Chicago, USA)
- Mercedes Perez-Rodriguez (New York, USA)
- Marco Pistis (Monserrato, Italy)
- Maurizio Popoli (Milano, Italy)
- Melanie Porter (Macquarie, Australia)
- Luise Poustka (Göttingen, Germany)
- Anita Riecher-Rössler (Basel, Switzerland)
- Angela Roberts (Cambridge, UK)
- Dan Rujescu (Halle, Germany)
- Barbara Sahakian (Cambridge, UK)
- Betty Jo Salmeron (Baltimore, USA)
- Richard Shelton (Birmingham, USA)
- Nicolas Singewald (Innsbruck, Austria)
- Tetsuya Suhara (Chiba, Japan)
- Kuei Y. Tseng (Chicago, USA)
- Gustavo Turecki (Montreal, Canada)
- Mark Underwood (New York, USA)
- Gustavo Vázquez (Buenos Aires, Argentina)
- Eduard Vieta (Barcelona, Spain)
- Anthony West (Chicago, USA)
- Jared Young (La Jolla, USA)
|
| | |
